Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T13057 | Target Info | |||
Target Name | Protein-tyrosine phosphatase SHP-2 (PTPN11) | ||||
Synonyms | Tyrosine-protein phosphatase non-receptor type 11; SHPTP2; SHP2; SHP-2; SH-PTP3; SH-PTP2; Protein-tyrosine phosphatase SHP2; Protein-tyrosine phosphatase 2C; Protein-tyrosine phosphatase 1D; PTP2C; PTP-2C; PTP-1D | ||||
Target Type | Clinical trial Target | ||||
Gene Name | PTPN11 | ||||
Biochemical Class | Phosphoric monoester hydrolase | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Adapter proteins | [+] 1 Adapter proteins | + | |||
Interacting Protein Name | Growth factor receptor-bound protein 2 (GRB2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | SH2/SH3 adapter GRB2; Protein Ash; Growth factor receptor-bound protein 2; ASH; Adapter protein GRB2 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [2] | |||
3 | Far Western | [3] | |||
4 | Reconstituted Complex | [4] | |||
Auxiliary transporters | [+] 1 Auxiliary transporters | + | |||
Interacting Target Name | Caveolin 1 (CAV1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Caveolin-1; Caveolin1; Cav-1; CAV | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [5] | |||
2 | Reconstituted Complex | [5] | |||
Cytokine receptors | [+] 1 Cytokine receptors | + | |||
Interacting Target Name | Erythropoietin Receptor (EPOR) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Full-length form; EPO-R | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [6] | |||
2 | Reconstituted Complex | [7] | |||
Kinases | [+] 11 Kinases | + | |||
Interacting Target Name | Epidermal growth factor receptor (EGFR) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Epidermal growth factor receptor variant III; Proto-oncogene c-ErbB-1 variant III; Receptor tyrosine-protein kinase erbB-1 variant III; EGFR variant III; ERBB variant III; ERBB1 variant III; HER1 variant III | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [8] | |||
2 | Affinity Capture-Western | [9] | |||
3 | Biochemical Activity | [10] | |||
4 | Protein-peptide | [11] | |||
5 | Yeast two hybrid | [12] | |||
Interacting Target Name | Erbb2 tyrosine kinase receptor (HER2) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tyrosine kinase-type cell surface receptor HER2; Tyrosine kinase receptor ErbB2; Receptor tyrosine-protein kinase erbB-2; Proto-oncogene Neu; Proto-oncogene c-ErbB-2; P185erbB2; NGL; NEU proto-oncogene; NEU; MLN19; MLN 19; Metastatic lymph node gene 19 protein; HER2/neu; HER2 (erbB2/neu); HER-2; Erb2; Epidermal growth factor receptor 2; C-erbB-2 oncoprotein; C-erbB-2; CD340 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [8] | |||
2 | Affinity Capture-Western | [13] | |||
3 | Protein-peptide | [11] | |||
4 | Yeast two hybrid | [12] | |||
Interacting Target Name | Vascular endothelial growth factor receptor 2 (KDR) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | VEGFR-2; VEGFR2; VEGF-2 receptor; Protein-tyrosine kinase receptor flk-1; Kinase insert domain receptor; FLK-1; FLK1; Fetal liver kinase 1; CD309 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [14] | |||
2 | Far Western | [14] | |||
3 | Yeast two hybrid | [12] | |||
Interacting Target Name | Insulin-like growth factor I receptor (IGF1R) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Type 1 insulin-like growth factor receptor; Insulin-like growth factor 1 receptor; IGF-IR; IGF-I receptor; IGF-1R; IGF-1 receptor; CD221 antigen; CD221 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [15] | |||
2 | Reconstituted Complex | [16] | |||
3 | Yeast two hybrid | [12] | |||
Interacting Target Name | Erbb4 tyrosine kinase receptor (Erbb-4) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tyrosine kinase-type cell surface receptor HER4; Receptor tyrosine-protein kinase erbB-4; Proto-oncogene-like protein c-ErbB-4; P180erbB4; HER4 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [8] | |||
2 | Yeast two hybrid | [12] | |||
Interacting Target Name | Insulin receptor (INSR) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | IR; CD220 antigen; CD220 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [17] | |||
2 | Reconstituted Complex | [18] | |||
Interacting Target Name | Janus kinase 2 (JAK-2) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tyrosine-protein kinase JAK2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [19] | |||
2 | Biochemical Activity | [4] | |||
Interacting Target Name | Tyrosine-protein kinase Kit (KIT) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog; Proto-oncogene tyrosine-protein kinase Kit; Proto-oncogene c-Kit; Piebald trait protein; PBT; p145 c-kit; Mast/stem cell growth factor receptor Kit; C-kit; CD117 antigen; CD117 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Protein-peptide | [20] | |||
2 | Reconstituted Complex | [21] | |||
Interacting Target Name | Janus kinase 1 (JAK-1) | Successful Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tyrosine-protein kinase JAK1; JAK1B; JAK1A | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [22] | |||
2 | Reconstituted Complex | [4] | |||
Interacting Target Name | Erbb3 tyrosine kinase receptor (Erbb-3) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tyrosine kinase-type cell surface receptor HER3; Receptor tyrosine-protein kinase erbB-3; Proto-oncogene-like protein c-ErbB-3; HER3; C-erbB-3 protein; C-erbB3 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [13] | |||
2 | Yeast two hybrid | [12] | |||
Interacting Target Name | Ephrin type-A receptor 2 (EPHA2) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Tyrosine-protein kinase receptor ECK; Epithelial cell kinase; EphA2receptor; ECK | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [23] | |||
2 | Yeast two hybrid | [12] | |||
Other proteins | [+] 7 Other proteins | + | |||
Interacting Target Name | Vitamin D3 up-regulated protein 1 (VDUP1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Vitamin D(3) up-regulating protein-1; Thioredoxin-interacting protein; Thioredoxin-binding protein 2 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Co-crystal Structure | [24] | |||
2 | Co-crystal Structure | [25] | |||
3 | Reconstituted Complex | [24] | |||
4 | Reconstituted Complex | [25] | |||
Interacting Target Name | Insulin receptor substrate-1 (IRS1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | IRS-1; Insulin receptor substrate 1 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [26] | |||
2 | Biochemical Activity | [27] | |||
3 | Reconstituted Complex | [28] | |||
Interacting Target Name | Platelet endothelial cell adhesion molecule (PECAM1) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | PECAM-1; PECA1; GPIIA'; EndoCAM; ECAM; CD31 antigen; CD31 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [29] | |||
2 | Far Western | [30] | |||
3 | Reconstituted Complex | [30] | |||
Interacting Target Name | Suppressor of cytokine signaling 3 (SOCS3) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | STAT-induced STAT inhibitor 3; STAT induced STAT inhibitor 3; SSI-3; SSI3; SOCS-3; Cytokine-inducible SH2 protein 3; CIS-3; CIS3 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [22] | |||
2 | Affinity Capture-Western | [31] | |||
3 | Reconstituted Complex | [22] | |||
Interacting Target Name | Proto-oncogene c-Crk (c-Crk) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | P38; Adapter molecule crk | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [32] | |||
2 | Affinity Capture-Western | [33] | |||
Interacting Protein Name | RNA polymerase-associated protein CTR9 homolog (CTR9) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | SH2BP1; TSBP; p150; p150TSP | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [34] | |||
2 | Proximity Label-MS | [35] | |||
Interacting Protein Name | RNA polymerase II-associated factor 1 homolog (PAF1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | F23149_1; PD2 | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [34] | |||
2 | Proximity Label-MS | [35] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Architecture of the human interactome defines protein communities and disease networks. Nature. 2017 May 25;545(7655):505-509. | ||||
REF 2 | Beta-chemokine receptor CCR5 signals through SHP1, SHP2, and Syk. J Biol Chem. 2000 Jun 9;275(23):17263-8. | ||||
REF 3 | Direct binding of Shc, Grb2, SHP-2 and p40 to the murine granulocyte colony-stimulating factor receptor. Biochim Biophys Acta. 1998 Nov 19;1448(1):70-6. | ||||
REF 4 | Molecular characterization of specific interactions between SHP-2 phosphatase and JAK tyrosine kinases. J Biol Chem. 1997 Jan 10;272(2):1032-7. | ||||
REF 5 | SHP-2 binds to caveolin-1 and regulates Src activity via competitive inhibition of CSK in response to H2O2 in astrocytes. PLoS One. 2014 Mar 14;9(3):e91582. | ||||
REF 6 | Tyrosine 425 within the activated erythropoietin receptor binds Syp, reduces the erythropoietin required for Syp tyrosine phosphorylation, and promotes mitogenesis. Blood. 1996 Jun 1;87(11):4495-501. | ||||
REF 7 | Involvement of SH2-containing phosphotyrosine phosphatase Syp in erythropoietin receptor signal transduction pathways. J Biol Chem. 1995 Mar 10;270(10):5631-5. | ||||
REF 8 | Phosphotyrosine interactome of the ErbB-receptor kinase family. Mol Syst Biol. 2005;1:2005.0008. | ||||
REF 9 | Association of SH2 domain protein tyrosine phosphatases with the epidermal growth factor receptor in human tumor cells. Phosphatidic acid activates receptor dephosphorylation by PTP1C. J Biol Chem. 1995 Sep 8;270(36):21277-84. | ||||
REF 10 | Multiple in vivo phosphorylated tyrosine phosphatase SHP-2 engages binding to Grb2 via tyrosine 584. Cell Growth Differ. 1996 Dec;7(12):1589-97. | ||||
REF 11 | A quantitative protein interaction network for the ErbB receptors using protein microarrays. Nature. 2006 Jan 12;439(7073):168-74. | ||||
REF 12 | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. Mol Cell. 2017 Jan 19;65(2):347-360. | ||||
REF 13 | Differential signaling by the epidermal growth factor-like growth factors neuregulin-1 and neuregulin-2. J Biol Chem. 1998 Oct 9;273(41):26954-61. | ||||
REF 14 | Type I collagen limits VEGFR-2 signaling by a SHP2 protein-tyrosine phosphatase-dependent mechanism 1. Circ Res. 2006 Jan 6;98(1):45-54. | ||||
REF 15 | Concerted activity of tyrosine phosphatase SHP-2 and focal adhesion kinase in regulation of cell motility. Mol Cell Biol. 1999 Apr;19(4):3125-35. | ||||
REF 16 | Localization of the insulin-like growth factor I receptor binding sites for the SH2 domain proteins p85, Syp, and GTPase activating protein. J Biol Chem. 1995 Aug 11;270(32):19151-7. | ||||
REF 17 | Adapter function of protein-tyrosine phosphatase 1D in insulin receptor/insulin receptor substrate-1 interaction. J Biol Chem. 1995 Dec 8;270(49):29189-93. | ||||
REF 18 | Insulin receptor kinase phosphorylates protein tyrosine phosphatase containing Src homology 2 regions and modulates its PTPase activity in vitro. Biochem Biophys Res Commun. 1994 Mar 15;199(2):780-5. | ||||
REF 19 | SHPTP2 serves adapter protein linking between Janus kinase 2 and insulin receptor substrates. Biochem Biophys Res Commun. 1996 Nov 1;228(1):122-7. | ||||
REF 20 | The adapter protein APS associates with the multifunctional docking sites Tyr-568 and Tyr-936 in c-Kit. Biochem J. 2003 Mar 15;370(Pt 3):1033-8. | ||||
REF 21 | The ubiquitously expressed Syp phosphatase interacts with c-kit and Grb2 in hematopoietic cells. J Biol Chem. 1994 Oct 7;269(40):25206-11. | ||||
REF 22 | SHP2 and SOCS3 contribute to Tyr-759-dependent attenuation of interleukin-6 signaling through gp130. J Biol Chem. 2003 Jan 3;278(1):661-71. | ||||
REF 23 | Activation of EphA2 kinase suppresses integrin function and causes focal-adhesion-kinase dephosphorylation. Nat Cell Biol. 2000 Feb;2(2):62-9. | ||||
REF 24 | Structural basis for the regulatory role of the PPxY motifs in the thioredoxin-interacting protein TXNIP. Biochem J. 2016 Jan 15;473(2):179-87. | ||||
REF 25 | Structural basis for a novel interaction between TXNIP and Vav2. FEBS Lett. 2016 Mar;590(6):857-65. | ||||
REF 26 | The COOH-terminal tyrosine phosphorylation sites on IRS-1 bind SHP-2 and negatively regulate insulin signaling. J Biol Chem. 1998 Oct 9;273(41):26908-14. | ||||
REF 27 | The Protein-tyrosine-phosphatase SHP2 is phosphorylated on serine residues 576 and 591 by protein kinase C isoforms alpha, beta 1, beta 2, and eta. Biochemistry. 2002 Jan 15;41(2):603-8. | ||||
REF 28 | The insulin receptor substrate 1 associates with the SH2-containing phosphotyrosine phosphatase Syp. J Biol Chem. 1993 Jun 5;268(16):11479-81. | ||||
REF 29 | Platelet-endothelial cell adhesion molecule-1 (CD31), a scaffolding molecule for selected catenin family members whose binding is mediated by different tyrosine and serine/threonine phosphorylation. J Biol Chem. 2000 Jul 14;275(28):21435-43. | ||||
REF 30 | Differential association of cytoplasmic signalling molecules SHP-1, SHP-2, SHIP and phospholipase C-gamma1 with PECAM-1/CD31. FEBS Lett. 1999 Apr 30;450(1-2):77-83. | ||||
REF 31 | SOCS3 exerts its inhibitory function on interleukin-6 signal transduction through the SHP2 recruitment site of gp130. J Biol Chem. 2000 Apr 28;275(17):12848-56. | ||||
REF 32 | Charting the molecular network of the drug target Bcr-Abl. Proc Natl Acad Sci U S A. 2009 May 5;106(18):7414-9. | ||||
REF 33 | Fibroblast growth factor receptor-1-mediated endothelial cell proliferation is dependent on the Src homology (SH) 2/SH3 domain-containing adaptor protein Crk. J Biol Chem. 1999 Sep 3;274(36):25726-34. | ||||
REF 34 | SHP2 tyrosine phosphatase converts parafibromin/Cdc73 from a tumor suppressor to an oncogenic driver. Mol Cell. 2011 Jul 8;43(1):45-56. | ||||
REF 35 | Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators. Cell Rep. 2016 Nov 22;17(9):2488-2501. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.